Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 24.373M	--
--	2024/Q4	-- / 26.701M	--
Nov 8, 2024	2024/Q3	18.461M / 23.263M	--
Aug 12, 2024	2024/Q2	22.798M / 23.019M	--
May 7, 2024	2024/Q1	19.931M / 22.220M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 24.373M--

--2024/Q4-- / 26.701M--

Nov 8, 20242024/Q318.461M / 23.263M--

Aug 12, 20242024/Q222.798M / 23.019M--

May 7, 20242024/Q119.931M / 22.220M--

Unlock Free Earnings Estimates

Open Account

Y-mAbs Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 8, 2024 07:20 ET

Y-mAbs Therapeutics | 8-K: Y-mAbs Reports Third Quarter 2024 Financial Results and Recent Corporate Developments

Nov 8, 2024 06:59 ET

Y-mAbs Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 12, 2024 07:10 ET

Y-mAbs Therapeutics | 8-K: Y-mAbs Reports Second Quarter 2024 Financial Results and Recent Corporate Developments

Aug 12, 2024 06:56 ET

Symbol Mini Chart % Chg

Unlock the Full List

Analysis

Updated: Feb 16, 2025

Strong Buy

No Data